Benitec Biopharma (BNTC) Receivables - Other (2019 - 2020)

Benitec Biopharma's (BNTC) quarterly Receivables - Other came in at $21000.0 in Q4 2020, down 64.41% quarter-over-quarter from $59000.0 in Q2 2020.

Benitec Biopharma (BNTC) Receivables - Other (2019 - 2020) Analysis & Trends

Benitec Biopharma has disclosed Receivables - Other across 2 years of filings, most recently posting $21000.0 for Q4 2020.

Receivables - Other for Q4 2020 came in at $21000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $21000.0 (changed N/A YoY), and the FY2020 annual result was $59000.0, down 96.89% from the prior year.
Receivables - Other came in at $21000.0 for Q4 2020 at Benitec Biopharma, down from $59000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $1.9 million in Q2 2019 to a low of $21000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn
9	Abivax	95.45 Bn	95.45 Bn	-
10	Benitec Biopharma	488.21 Mn	488.21 Mn	-

Download Data